Bilaketaren emaitzak - Jan Eickhoff

  • Erakusten 1 - 11 emaitzak -- 11
Findu emaitzak
  1. 1
    Characterization of molecular and cellular functions of the cyclin‐dependent kinase <scp>CDK9</scp> using a novel specific inhibitor

    Characterization of molecular and cellular functions of the cyclin‐dependent kinase <scp>CDK9</scp> using a novel specific inhibitor nork Thomas Albert, Caroline Rigault, Jan Eickhoff, Karen Baumgart, Claudia Antrecht, Bert Klebl, Gerhard Mittler, Michael Meisterernst

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Cyclin-Dependent Kinase 7 Controls mRNA Synthesis by Affecting Stability of Preinitiation Complexes, Leading to Altered Gene Expression, Cell Cycle Progression, and Survival of Tumor Cells

    Cyclin-Dependent Kinase 7 Controls mRNA Synthesis by Affecting Stability of Preinitiation Complexes, Leading to Altered Gene Expression, Cell Cycle Progression, and Survival of Tum... nork Timothy W. R. Kelso, Karen Baumgart, Jan Eickhoff, Thomas Albert, Claudia Antrecht, Sarah Lemcke, Bert Klebl, Michael Meisterernst

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations

    A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations nork Corina Hutterer, Jan Eickhoff, Jens Milbradt, Klaus Korn, Isabel Zeitträger, Hanife Bahsi, Sabrina Wagner, Gunther Zischinsky, Alexander Wolf, Carsten Degenhart, Anke Unger, Matthias Baumann, Bert Klebl, Manfred Marschall

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Stabilization of protein-protein interactions in drug discovery

    Stabilization of protein-protein interactions in drug discovery nork Sebastian A. Andrei, Eline Sijbesma, Michael M. Hann, Jeremy Davis, Gavin O’Mahony, Matthew W. D. Perry, Anna Karawajczyk, Jan Eickhoff, Luc Brunsveld, Richard G. Doveston, L.‐G. Milroy, Christian Ottmann

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Proteomic Characterization of the Angiogenesis Inhibitor SU6668 Reveals Multiple Impacts on Cellular Kinase Signaling

    Proteomic Characterization of the Angiogenesis Inhibitor SU6668 Reveals Multiple Impacts on Cellular Kinase Signaling nork Klaus Godl, Oliver J. Gruß, Jan Eickhoff, Josef Wissing, Stephanie Blencke, Martina Weber, Heidrun Degen, Dirk Brehmer, László Örfi, Zoltán Horváth, Gÿorgý Kéri, Stefan C. Müller, Matthew Cotten, Axel Ullrich, Henrik Daub

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    IFNα primes cancer cells for Fusicoccin-induced cell death via 14-3-3 PPI stabilization

    IFNα primes cancer cells for Fusicoccin-induced cell death via 14-3-3 PPI stabilization nork Blaž Andlovic, Geronimo Heilmann, Sabrina Ninck, Sebastian A. Andrei, Federica Centorrino, Yusuke Higuchi, Nobuo Kato, Luc Brunsveld, Michelle R. Arkin, Sascha Menninger, Axel Choidas, Alexander Wolf, Bert Klebl, Farnusch Kaschani, Markus Kaiser, Jan Eickhoff, Christian Ottmann

    Argitaratua 2023
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Modulators of 14-3-3 Protein–Protein Interactions

    Modulators of 14-3-3 Protein–Protein Interactions nork Loes M. Stevers, Eline Sijbesma, Maurizio Botta, Carol MacKintosh, Tomáš Obšil, Isabelle Landrieu, Ylenia Cau, Andrew J. Wilson, Anna Karawajczyk, Jan Eickhoff, Jeremy Davis, Michael M. Hann, Gavin O’Mahony, Richard G. Doveston, Luc Brunsveld, Christian Ottmann

    Argitaratua 2017
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells

    The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells nork Magdalena Paolino, Axel Choidas, Stephanie Wallner, Blanka Pranjic, Iris Uribesalgo, Stefanie Loeser, A. M. Jamieson, Wallace Y. Langdon, Fumiyo Ikeda, Juan Pablo Fededa, Shane J. F. Cronin, Roberto Nitsch, Carsten Schultz‐Fademrecht, Jan Eickhoff, Sascha Menninger, Anke Unger, Robert Torka, Thomas Gruber, Reinhard Hinterleitner, Gottfried Baier, Dominik Wolf‎, Axel Ullrich, Bert Klebl, Josef Penninger

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer

    Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer nork Ulrich Lücking, Arne Scholz, Philip Lienau, Gerhard Siemeister, Dirk Kosemund, Rolf Bohlmann, Hans Briem, Ildiko Terebesi, Kirstin Meyer, Katja Prelle, Karsten Denner, Ulf Bömer, Martina Schäfer, Knut Eis, Ray Valencia, Stuart Ince, Franz von Nussbaum, Dominik Mumberg, Karl Ziegelbauer, Bert Klebl, Axel Choidas, Peter Nußbaumer, Matthias Baumann, Carsten Schultz‐Fademrecht, Gerd Rühter, Jan Eickhoff, Michael Brands

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo

    Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo nork Lydia Reinhardt, Susanne Kordes, Peter Reinhardt, Michael Glatza, Matthias Baumann, Hannes C. A. Drexler, Sascha Menninger, Gunther Zischinsky, Jan Eickhoff, Claudia Fröb, Prabesh Bhattarai, Guruchandar Arulmozhivarman, Lara Marrone, Antje Janosch, Kenjiro Adachi, Martin Stehling, Eric N. Anderson, Masin Abo-Rady, Marc Bickle, Udai Bhan Pandey, Michell M. Reimer, Çağhan Kızıl, Hans R. Schöler, Peter Nußbaumer, Bert Klebl, Jared Sterneckert

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma

    Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma nork Johannes Brägelmann, Marcel A. Dammert, Felix Dietlein, Johannes M. Heuckmann, Axel Choidas, Stefanie Böhm, André Richters, Debjit Basu, Verena Tischler, Carina Lorenz, Peter Habenberger, Zhizhou Fang, Sandra Ortiz‐Cuaran, Frauke Leenders, Jan Eickhoff, Uwe Koch, Matthäus Getlik, Martin Termathe, Muhammad Sallouh, Zoltán Greff, Zoltán Varga, Hyatt Balke‐Want, Christopher A. French, Martin Peifer, Hans Christian Reinhardt, László Örfi, Gÿorgý Kéri, Sascha Ansén, Lukas C. Heukamp, Reinhard Büttner, Daniel Rauh, Bert Klebl, Roman K. Thomas, Martin L. Sos

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: